Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

22 works

Work: Nivolumab Combined with Chemotherapy in FGFR2 and PD-L1 Co- Expressing Metastatic Gastric Cancer: A Prospective Phase 2 NIVOFGFR2 Study

  1. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

    Yelena Y. Janjigian, Kohei Shitara, Markus Moehler +26

    Article20212 citations
    ABI

  2. Untitled

    Other1 citations
    ABI

  3. Untitled

    Other1 citations
    ABI

  4. Untitled

    Other1 citations
    ABI

  5. Untitled

    Other1 citations
    ABI

  6. Untitled

    Other1 citations
    ABI

  7. Untitled

    Other1 citations
    ABI

  8. Untitled

    Other1 citations
    ABI

  9. Untitled

    Other1 citations
    ABI

  10. Untitled

    Other1 citations
    ABI

  11. Untitled

    Other1 citations
    ABI

  12. Untitled

    Other1 citations
    ABI

  13. Untitled

    Other1 citations
    ABI

  14. Untitled

    Other1 citations
    ABI

  15. Untitled

    Other1 citations
    ABI

  16. Untitled

    Other1 citations
    ABI

  17. Untitled

    Other1 citations
    ABI

  18. Untitled

    Other1 citations
    ABI

  19. Untitled

    Other1 citations
    ABI

  20. Untitled

    Other1 citations
    ABI

  21. Untitled

    Other1 citations
    ABI

  22. Untitled

    Other1 citations
    ABI